Cargando…
Qualitative differences in disease-associated MEK mutants reveal molecular signatures and aberrant signaling-crosstalk in cancer
Point-mutations of MEK1, a central component of ERK signaling, are present in cancer and RASopathies, but their precise biological effects remain obscure. Here, we report a mutant MEK1 structure that uncovers the mechanisms underlying abnormal activities of cancer- and RASopathy-associated MEK1 muta...
Autores principales: | Kubota, Yuji, Fujioka, Yuko, Patil, Ashwini, Takagi, Yusuke, Matsubara, Daisuke, Iijima, Masatomi, Momose, Isao, Naka, Ryosuke, Nakai, Kenta, Noda, Nobuo N., Takekawa, Mutsuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279491/ https://www.ncbi.nlm.nih.gov/pubmed/35831322 http://dx.doi.org/10.1038/s41467-022-31690-w |
Ejemplares similares
-
Caspase 3‐specific cleavage of MEK1 suppresses ERK signaling and sensitizes cells to stress‐induced apoptosis
por: Moriizumi, Hisashi, et al.
Publicado: (2023) -
WGA-based lectin affinity gel electrophoresis: A novel method for the detection of O-GlcNAc-modified proteins
por: Kubota, Yuji, et al.
Publicado: (2017) -
Atg1 family kinases in autophagy initiation
por: Noda, Nobuo N., et al.
Publicado: (2015) -
TimeXNet: Identifying active gene sub-networks using time-course gene expression profiles
por: Patil, Ashwini, et al.
Publicado: (2014) -
ERK-mediated NELF-A phosphorylation promotes transcription elongation of immediate-early genes by releasing promoter-proximal pausing of RNA polymerase II
por: Ohe, Seina, et al.
Publicado: (2022)